‘‘(B) is conducted by the Department of 
Health and Human Services, the Department of 
Justice, or the Department of Veterans Affairs 
or is funded partly or entirely by a grant, con-
tract, cooperative agreement, or other trans-
action from the Department of Health and 
Human Services, the Department of Justice, or 
the Department of Veterans Affairs. 
‘‘(3) ELECTRONIC SUBMISSIONS.—The Attorney 
General shall provide a means to allow practitioners 
to submit notifications under paragraph (1) elec-
tronically. 
‘‘(4) LIMITATION ON AMOUNTS.—A practitioner 
conducting research with a controlled substance in 
schedule I pursuant to this subsection shall be al-
lowed to possess only the amounts of the controlled 
substance in schedule I identified in— 
‘‘(A) the notification to the Attorney Gen-
eral under paragraph (1); or 
‘‘(B) if the practitioner needs additional 
amounts for the research, a supplemental notifi-
cation under this subsection that includes the 
practitioner’s name, the additional quantity 
needed of the substance, and an attestation 
that the research to be conducted with the sub-
VerDate Sep 11 2014 
20:31 Mar 09, 2022
Jkt 029200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H6946.IH
H6946
pamtmann on DSKBC07HB2PROD with BILLS
stance is consistent with the scope of the re-
search that was the subject of the notification 
under paragraph (1). 
‘‘(5) IMPORTATION
AND
EXPORTATION
RE-
QUIREMENTS NOT AFFECTED.—Nothing in this sec-
tion alters the requirements of part A of title III re-
garding the importation and exportation of con-
trolled substances.’’. 
(b) SEPARATE REGISTRATIONS NOT REQUIRED FOR 
ADDITIONAL RESEARCHER IN SAME INSTITUTION.—Sub-
section (c) of section 302 of the Controlled Substances Act 
(21 U.S.C. 822) is amended by adding at the end the fol-
lowing: 
‘‘(4) An agent or employee of a research insti-
tution that is conducting research with a controlled 
substance if— 
‘‘(A) such agent or employee is acting 
within the scope of his or her professional prac-
tice; 
‘‘(B) another agent or employee of such in-
stitution is registered to conduct research with 
a controlled substance in the same schedule; 
‘‘(C) the researcher who is so registered— 
‘‘(i) informs the Attorney General of 
the name, position title, and employing in-
VerDate Sep 11 2014 
20:31 Mar 09, 2022
Jkt 029200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6201
E:\BILLS\H6946.IH
H6946
pamtmann on DSKBC07HB2PROD with BILLS
stitution of the agent or employee who is 
not separately registered; 
‘‘(ii) authorizes such agent or em-
ployee to perform research under the reg-
istered researcher’s registration; and 
‘‘(iii) affirms that all acts taken by 
such agent or employee involving controlled 
substances shall be attributable to the reg-
istered researcher, as if the researcher had 
directly committed such acts, for purposes 
of any proceeding under section 304(a) to 
suspend or revoke the registration of the 
registered researcher; and 
‘‘(D) the Attorney General does not, within 
30 days of receiving the information, authoriza-
tion, and affirmation described in subparagraph 
(C), refuse, for a reason listed in section 
304(a), to allow such agent or employee to pos-
sess such substance without a separate registra-
tion.’’. 
(c) SINGLE REGISTRATION FOR RELATED RESEARCH 
SITES.—Such section 302(e) of the Controlled Substances 
Act (21 U.S.C. 822(e)) is amended by adding at the end 
the following: 
VerDate Sep 11 2014 
20:31 Mar 09, 2022
Jkt 029200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6201
E:\BILLS\H6946.IH
H6946
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(3)(A) Notwithstanding paragraph (1), a person 
registered to conduct research with a controlled substance 
under section 303(f) may conduct such research at mul-
tiple sites under a single registration if— 
‘‘(i) such research occurs exclusively at sites 
which are all within the same city or county and are 
all under the control of the same institution, organi-
zation, or agency; and 
‘‘(ii) the researcher notifies the Attorney Gen-
eral, prior to commencing such research, of all sites 
where— 
‘‘(I) the research will be conducted; or 
‘‘(II) the controlled substance will be 
stored or administered. 
‘‘(B) A site described by subparagraph (A) shall be 
included in such registration only if the researcher has no-
tified the Attorney General of such site— 
‘‘(i) in the application for such registration; or 
‘‘(ii) before the research is conducted, or before 
the controlled substance is stored or administered, at 
such site. 
‘‘(C) The Attorney General may, in consultation with 
the Secretary of Health and Human Services, issue regu-
lations addressing— 
VerDate Sep 11 2014 
20:31 Mar 09, 2022
Jkt 029200
PO 00000
Frm 00023
Fmt 6652
Sfmt 6201
E:\BILLS\H6946.IH
H6946
pamtmann on DSKBC07HB2PROD with BILLS